WAVEMAN · COMPANY

ECVT · Ecovyst Inc.

LIVE

TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV-1.12% 13F +693CRM-0.46% 13F +1,018CVNA+2.74% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+15.81% 13F +1,203CRWD-5.42% 13F +1,382ANET+2.87% 13F +1,323COIN-1.05% 13F +475

← ALL COMPANIES

ECVT

Name: Ecovyst Inc. (ECVT) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

Ecovyst Inc.

PHARMA & BIOTECH · CHEMICALS & ALLIED PRODUCTS · CIK 0001708035

FORM 144 · 1☆ WATCH

INSIDER NET · 180D

-$112.6K

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

126

13F, latest reported quarter

REVENUE GROWTH

+20.9%

XBRL, annual

NET MARGIN

-9.8%

CONVERSIONS · 180D

codes C/M, not in net · $115.7K priced

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

net -$112.6K over 180 days

more than 55% of Pharma & Biotech

CONGRESS

no member of Congress has reported trading it

FUNDS

126 funds added or opened last quarter

more than 74% of Pharma & Biotech

REVENUE

+20.9% year over year

more than 70% of Pharma & Biotech

MARGIN

-9.8% net margin

more than 56% of Pharma & Biotech

BUYBACKS

$36.3M repurchased, FY to 2026-06-30

more than 50% of Pharma & Biotech

SHORT

3.7% of shares outstanding short · 3.2 days to cover · settled 2026-07-31

below 54% of Pharma & Biotech

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

126 funds added or opened positions in the latest 13F quarter, of 211 holders.

The year, with the filings on it

Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail

TOTAL 12M RETURN +14.6%

+14.6%12M

INSIDER SELLFORM 144

INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

Insiders have filed to sell — before selling.

The record shows a net $112.6K sold by insiders over 180 days, 126 funds added last quarter, $385.5K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

UTHR CPIX MRNA REGN LLY ALNY ELF CITR MDGL DNA VRTX NUVL

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, Ecovyst Inc. insiders sold a net $112.6K of stock across 115 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-04.

INSIDER

FILED

VALUE

Lorance Sarah

Director

SELL

2026-06-02

8,450.0

$112.6K

Ward Susan F

Director

SELL

2025-11-07

15,000.0

$126.0K

Whittleston Paul

See Remarks

BUY

2024-08-07

7,800.0

$50.8K

Koscinski Joseph S.

See Remarks

BUY

2024-08-05

4,807.0

$30.1K

Feehan Michael

See Remarks

BUY

2024-08-05

16,000.0

$100.5K

115 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 110 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

10,666,032.0 sh

$132.8M

Rubric Capital Management LP

8,211,888.0 sh

$102.2M

DIMENSIONAL FUND ADVISORS LP

6,585,047.0 sh

$82.0M

VANGUARD PORTFOLIO MANAGEMENT LLC

6,090,922.0 sh

$75.8M

FMR LLC

5,333,701.0 sh

$66.4M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

Planned sales · Form 144

Filed before the sale — intent, not a trade

Susan Ward

FILED 2026-07-17

$385.5K

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

BALLAST SMALL/MID CAP ETF

$5.1M POSITION · AS OF 2026-03-31

3.1%

Brown Advisory Small-Cap Fundamental Value Fund

$28.5M POSITION · AS OF 2026-03-31

2.6%

Hotchkis and Wiley Small Cap Value Fund

$15.6M POSITION · AS OF 2026-03-31

2.4%

Brown Advisory Sustainable Small-Cap Core Fund

$2.5M POSITION · AS OF 2026-03-31

2.4%

American Beacon Shapiro SMID Cap Equity Fund

$414.1K POSITION · AS OF 2026-03-31

1.9%

HW Opportunities MP Fund

$1.2M POSITION · AS OF 2026-03-31

1.6%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$723.5M	$598.3M	$584.8M	$820.2M
GROSS PROFIT	$158.1M	$163.4M	$166.4M	$224.6M
OPERATING INCOME	$64.9M	$85.1M	$89.6M	$104.4M
NET INCOME	$-71.1M	$-6.7M	$71.2M	$69.8M
EPS (DILUTED)	-0.61	-0.06	0.60	0.55
OPERATING CASH FLOW	$140.3M	$149.9M	$137.6M	$186.6M
CASH	$197.2M	$131.4M	$88.4M	$110.9M
LONG-TERM DEBT	$392.6M	$852.1M	$858.9M	$865.9M
BUYBACKS	$46.9M	$5.0M	$78.7M	$136.7M
DIVIDENDS PAID	—	—	$0	$0

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-04 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE